Home Excelencia Severo Ochoa
Selected papers
Fuster JJ, González-Navarro H, Vinué A, Molina P, Andrés-Manzano MJ, Nakayama KI, Nakayama K, Díez-Juan A, Bernad A, Rodríguez C, Martínez-González J, Andrés V. Deficient p27 Phosphorylation at Serine 10 Increases Macrophage Foam Cell Formation and Aggravates Atherosclerosis Through a Proliferation-Independent Mechanism. Arterioscler Thromb Vasc Biol (2011) 31:2455-2463
Josowitz R, Carvajal-Vergara X, Lemischka IR, Gelb BD. Induced pluripotent stem cell-derived cardiomyocytes as models for genetic cardiovascular disordersCurr Opin Cardiol (2011) 26:223-9
Tomé M, López-Romero P, Albo C, Sepúlveda JC, Fernández-Gutiérrez B, Dopazo A, Bernad A, González MA. miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ (2011) 18:985-95
Carvajal-Vergara X, Sevilla A, D'Souza SL, Ang YS, Schaniel C, Lee DF, Yang L, Kaplan AD, Adler ED, Rozov R, Ge Y, Cohen N, Edelmann LJ, Chang B, Waghray A, Su J, Pardo S, Lichtenbelt KD, Tartaglia M, Gelb BD, Lemischka IR. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature (2010) 465:808-12
Lucena J, Pezzi S, Aso E, Valero MC, Carreiro C, Dubus P, Sampaio A, Segura M, Barthelemy I, Zindel MY, Sousa N, Barbero JL, Maldonado R, Pérez-Jurado LA, Campuzano V. Essential role of the N-terminal region of TFII-I in viability and behavior. Bmc Med Genet (2010) 11:61
Bailey B, Izarra A, Alvarez R, Fischer KM, Cottage CT, Quijada P, Diez-Juan A, Sussman MA. Cardiac stem cell genetic engineering using the alphaMHC promoterRegen Med (2009) 4:823-33
Orgaz JL, Ladhani O, Hoek KS, Fernandez-Barral A, Mihic D, Aguilera O, Seftor EA, Bernad A, Rodriguez-Peralto JL, Hendrix MJ, Volpert OV, Jimenez B. Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma'Oncogene (2009) 28:4147-61
Gago N, Perez-Lopez V, Sanz-Jaka JP, Cormenzana P, Eizaguirre I, Bernad A, Izeta A. Age-dependent depletion of human skin-derived progenitor cells. Stem Cells (2009) 27:1164-72
Gonzalez MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum (2009) 60:1006-19
Jalife J, Atienza F, Lopez-Salazar B, Delpon E, Sanchez-Quintana D, Bernad A, Almendral J. Molecular, cellular and pathophysiological mechanisms of human atrial fi brillationNat Rev Cardiol (cnic Edition) (2009) 6:15-21
23 Record/s1,2,3[>/>>]
Antonio Bernad
  • Antonio Bernad Miana
  • Platform Director
  • Ext.3300

Antonio Bernad Miana studied Chemical Sciences at the Universidad de Zaragoza and moved to the Universidad Autónoma de Madrid to specialize in Biochemistry and Molecular Biology (1980-84). He went on to complete his PhD (1985-89) at the Centro de Biología Molecular Severo Ochoa (Madrid) under the supervision of Margarita Salas and Luis Blanco. From 1990 to 1993 he worked as a Senior Researcher in the Department of Biological Effects at the Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) in Madrid, where he developed techniques for somatic gene transfer to hematopoieitc stem cells. In 1993 he was an invited researcher at the Center for Blood Research at Harvard Medical School, after which, in 1994, he joined the Centro Nacional de Biotecnología (CNB) in Madrid as a CSIC Científico Titular. At the CNB, first in the Department of Molecular Biology and later in the Department of Immunology and Oncology, he built and directed a research team focused on the biology of hematopoietic and mesechymal stem cells and their use in tissue engineering. In 2006 he was promoted to Profesor de Investigación, the highest category for researchers in the CSIC. In 2007 he moved his research group to the CNIC.